Related Experiment Video
Updated: Jun 16, 2026

06:53
A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
Published on: July 9, 2020
Filter-protected versus unprotected carotid artery stenting: a randomised trial
Sumaira Macdonald1, David H Evans, Paul D Griffiths
1Vascular Radiology, Freeman Hospital, Newcastle upon Tyne, UK. Sumaira.macdonald@nuth.nhs.uk
Cerebrovascular Diseases (Basel, Switzerland)
|January 22, 2010
Summary
Filter protection during carotid artery stenting (CAS) did not reduce brain embolisation. In fact, filter-protected CAS showed more new brain lesions on DWI and higher microembolisation rates on TCD compared to unprotected CAS.
Area of Science:
- Neurology
- Vascular Surgery
- Medical Imaging
Background:
- Carotid artery stenting (CAS) is a procedure to treat symptomatic carotid artery stenosis.
- Embolisation to the brain is a potential complication during CAS.
Purpose of the Study:
- To investigate whether using a filter during CAS reduces embolisation to the brain.
- To compare brain lesion incidence and microembolisation rates between filter-protected and unprotected CAS.
Main Methods:
- Thirty patients with >70% symptomatic carotid artery stenosis were randomized to filter-protected or unprotected CAS.
- Diffusion-weighted magnetic resonance imaging (DWI) assessed new brain lesions before and after CAS.
- Transcranial Doppler (TCD) monitored high-intensity transient signals (emboli) during the procedure.
Main Results:
- No significant differences in patient demographics or presenting symptoms between groups.
- Filter-protected CAS showed a trend towards more new DWI lesions at 1-3 hours (29% vs 18%) and 30 days (26% vs 12%).
- Significantly higher total and particulate emboli counts were observed on TCD during filter-protected CAS (p=0.01 and p=0.03).
Conclusions:
- Filter-protected CAS is associated with increased new brain lesions on DWI and higher microembolisation rates on TCD.
- The clinical significance of these findings warrants further investigation.
- Current evidence suggests filter protection may not reduce, and could potentially increase, embolic events during CAS.